FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891938588> ?p ?o ?g. }

• W2891938588 abstract "Background Patients who have had an acute coronary syndrome ( ACS ) are at increased risk of recurrent cardiovascular events; however, paradoxically, high‐risk patients who may derive the greatest benefit from guideline‐recommended therapies are often undertreated. The aim of our study was to examine the management, clinical outcomes, and temporal trends of patients after ACS stratified by the Thrombolysis in Myocardial Infarction (TIMI) risk score for secondary prevention, a recently validated clinical tool that incorporates 9 clinical risk factors. Methods and Results Included were patients with ACS enrolled in the biennial Acute Coronary Syndrome Israeli Surveys ( ACSIS ) between 2008 and 2016. Patients were stratified by the TIMI risk score for secondary prevention to low (score 0–1), intermediate (2), or high (≥3) risk. Clinical outcomes included 30‐day major adverse cardiac events (death, myocardial infarction, stroke, unstable angina, stent thrombosis, urgent revascularization) and 1‐year mortality. Of 6827 ACS patients enrolled, 35% were low risk, 27% were intermediate risk, and 38% were high risk. Compared with the other risk groups, high‐risk patients were older, were more commonly female, and had more renal dysfunction and heart failure ( P <0.001 for each). High‐risk patients were treated less commonly with guideline‐recommended therapies during hospitalization (percutaneous coronary intervention) and at discharge (statins, dual‐antiplatelet therapy, cardiac rehabilitation). Overall, high‐risk patients had higher rates of 30‐day major adverse cardiac events (7.2% low, 8.2% intermediate, and 15.1% high risk; P <0.001) and 1‐year mortality (1.9%, 4.6%, and 15.8%, respectively; P <0.001). Over the past decade, utilization of guideline‐recommended therapies has increased among all risk groups; however, the rate of 30‐day major adverse cardiac events has significantly decreased among patients at high risk but not among patients at low and intermediate risk. Similarly, the 1‐year mortality rate has decreased numerically only among high‐risk patients. Conclusions Despite an improvement in the management of high‐risk ACS patients, they are still undertreated with guideline‐recommended therapies. Nevertheless, the outcome of high‐risk patients after ACS has significantly improved in the past decade, thus they should not be denied these therapies." @default.
• W2891938588 created "2018-09-27" @default.
• W2891938588 creator A5004901668 @default.
• W2891938588 creator A5015063403 @default.
• W2891938588 creator A5039789130 @default.
• W2891938588 creator A5051776383 @default.
• W2891938588 creator A5055933161 @default.
• W2891938588 creator A5059052503 @default.
• W2891938588 creator A5060313288 @default.
• W2891938588 creator A5079579563 @default.
• W2891938588 creator A5079832597 @default.
• W2891938588 creator A5088995880 @default.
• W2891938588 date "2018-09-18" @default.
• W2891938588 modified "2023-10-17" @default.
• W2891938588 title "Guideline‐Recommended Therapies and Clinical Outcomes According to the Risk for Recurrent Cardiovascular Events After an Acute Coronary Syndrome" @default.
• W2891938588 cites W1520609538 @default.
• W2891938588 cites W2046405657 @default.
• W2891938588 cites W2075740857 @default.
• W2891938588 cites W2090766413 @default.
• W2891938588 cites W2100089051 @default.
• W2891938588 cites W2105397247 @default.
• W2891938588 cites W2114995492 @default.
• W2891938588 cites W2124724401 @default.
• W2891938588 cites W2128312747 @default.
• W2891938588 cites W2133677561 @default.
• W2891938588 cites W21478844 @default.
• W2891938588 cites W2152094259 @default.
• W2891938588 cites W2155243998 @default.
• W2891938588 cites W2159449551 @default.
• W2891938588 cites W2168907840 @default.
• W2891938588 cites W2170949977 @default.
• W2891938588 cites W2296998040 @default.
• W2891938588 cites W2312388685 @default.
• W2891938588 cites W2498004564 @default.
• W2891938588 cites W2589921037 @default.
• W2891938588 cites W2754054868 @default.
• W2891938588 cites W2790815716 @default.
• W2891938588 cites W3150595609 @default.
• W2891938588 doi "https://doi.org/10.1161/jaha.118.009885" @default.
• W2891938588 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6222928" @default.
• W2891938588 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30371188" @default.
• W2891938588 hasPublicationYear "2018" @default.
• W2891938588 type Work @default.
• W2891938588 sameAs 2891938588 @default.
• W2891938588 citedByCount "19" @default.
• W2891938588 countsByYear W28919385882019 @default.
• W2891938588 countsByYear W28919385882020 @default.
• W2891938588 countsByYear W28919385882021 @default.
• W2891938588 countsByYear W28919385882022 @default.
• W2891938588 countsByYear W28919385882023 @default.
• W2891938588 crossrefType "journal-article" @default.
• W2891938588 hasAuthorship W2891938588A5004901668 @default.
• W2891938588 hasAuthorship W2891938588A5015063403 @default.
• W2891938588 hasAuthorship W2891938588A5039789130 @default.
• W2891938588 hasAuthorship W2891938588A5051776383 @default.
• W2891938588 hasAuthorship W2891938588A5055933161 @default.
• W2891938588 hasAuthorship W2891938588A5059052503 @default.
• W2891938588 hasAuthorship W2891938588A5060313288 @default.
• W2891938588 hasAuthorship W2891938588A5079579563 @default.
• W2891938588 hasAuthorship W2891938588A5079832597 @default.
• W2891938588 hasAuthorship W2891938588A5088995880 @default.
• W2891938588 hasBestOaLocation W28919385881 @default.
• W2891938588 hasConcept C11783203 @default.
• W2891938588 hasConcept C126322002 @default.
• W2891938588 hasConcept C142724271 @default.
• W2891938588 hasConcept C164705383 @default.
• W2891938588 hasConcept C177713679 @default.
• W2891938588 hasConcept C2777698277 @default.
• W2891938588 hasConcept C2777785093 @default.
• W2891938588 hasConcept C2777995511 @default.
• W2891938588 hasConcept C2779134260 @default.
• W2891938588 hasConcept C2779464278 @default.
• W2891938588 hasConcept C2779581417 @default.
• W2891938588 hasConcept C2780182762 @default.
• W2891938588 hasConcept C2780400711 @default.
• W2891938588 hasConcept C500558357 @default.
• W2891938588 hasConcept C71924100 @default.
• W2891938588 hasConceptScore W2891938588C11783203 @default.
• W2891938588 hasConceptScore W2891938588C126322002 @default.
• W2891938588 hasConceptScore W2891938588C142724271 @default.
• W2891938588 hasConceptScore W2891938588C164705383 @default.
• W2891938588 hasConceptScore W2891938588C177713679 @default.
• W2891938588 hasConceptScore W2891938588C2777698277 @default.
• W2891938588 hasConceptScore W2891938588C2777785093 @default.
• W2891938588 hasConceptScore W2891938588C2777995511 @default.
• W2891938588 hasConceptScore W2891938588C2779134260 @default.
• W2891938588 hasConceptScore W2891938588C2779464278 @default.
• W2891938588 hasConceptScore W2891938588C2779581417 @default.
• W2891938588 hasConceptScore W2891938588C2780182762 @default.
• W2891938588 hasConceptScore W2891938588C2780400711 @default.
• W2891938588 hasConceptScore W2891938588C500558357 @default.
• W2891938588 hasConceptScore W2891938588C71924100 @default.
• W2891938588 hasIssue "18" @default.
• W2891938588 hasLocation W28919385881 @default.
• W2891938588 hasLocation W28919385882 @default.
• W2891938588 hasLocation W28919385883 @default.
• W2891938588 hasOpenAccess W2891938588 @default.
• W2891938588 hasPrimaryLocation W28919385881 @default.
• W2891938588 hasRelatedWork W136901553 @default.
• W2891938588 hasRelatedWork W2086461862 @default.

• next